CVS Health Corporation (CVS) Under Pressure From Medicare Proposal, Argus Holds Positive View

12 Unstoppable Dividend Stocks to Buy According to Analysts.

On January 28, Argus trimmed its terms proposal connected CVS Health Corporation (NYSE:CVS) to $90 from $91. However, the steadfast maintained a Buy standing connected the stock. The shares fell astir 15% aft the Centers for Medicare and Medicaid Services projected keeping Medicare Advantage reimbursement rates level for 2027 compared with 2026. Argus said that the connection is apt to beryllium revised higher earlier the last determination successful April 2026. The expert besides noted that adjacent if the last summation comes successful beneath past year’s 5.1% hike, CVS’s diversified concern should assistance cushion the interaction amended than companies that trust solely connected wellness insurance.

On February 5, CVS announced changes to its preferred cause lists that volition instrumentality effect connected April 1. The institution said it volition regenerate definite bony illness treatments from Amgen and Eli Lilly with lower-cost alternatives. Through its pharmacy payment absorption unit, Caremark, CVS plans to adhd biosimilar versions of Amgen’s Prolia, including Ospomyv from its Cordavis portion and Celltrion’s Stoboclo. It volition besides see generic alternatives to Lilly’s Forteo, specified arsenic Bonsity and Tymlos, crossed large nationalist commercialized formularies.

CVS said the changes are expected to chopped medicine costs by much than 50% compared with branded drugs. The institution added that its biosimilar formulary strategy has already generated $1.5 cardinal successful gross savings for customers and their members.

CVS Health Corporation (NYSE:CVS) operates arsenic a wellness solutions institution with businesses spanning wellness insurance, pharmacy services, retail pharmacy operations, and related healthcare offerings.

While we admit the imaginable of CVS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Best Wide Moat Dividend Stocks to Invest in and 13 Best Long Term Low Risk Stocks to Buy Now

Disclosure: None.